MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Real-world database analysis of new-onset hypotension and medications for orthostatic hypotension prescribing patterns in patients with Parkinson’s Disease receiving MAO-B Inhibitors and levodopa in Japan

    M. Nagai, R. Ando, K. Sasaki, Y. Tomita, K. Daidoji, Y. Kogo, T. Ishida (Ehime, Japan)

    Objective: To evaluate the incidence of claims-defined new-onset hypotension and the prescribing patterns of medications for orthostatic hypotension in patients with Parkinson’s disease (PD) treated…
  • 2026 International Congress

    Suicidal Ideation and the Hippocampal Histaminergic System in Huntington’s Disease: A PET Study

    P. Eze, C. Madrigal-Esquivel, O. Makos, A. Rangel-Cristales, J. Valera-Bermejo, M. Moretto, N. Martin, P. Tall, J. Staunton, M. Hartmann, F. Turkheimer, J. Badenoch, M. Veronese, N. Palasits, A. Wood, S. Williams, D. van Wamelen (London, United Kingdom)

    Objective: To determine whether presence and severity of suicidal ideation (SI) are associated with hippocampal volume and histamine H3 receptor (H3R) PET uptake in people with Huntington’s disease (PwHD). Background: Suicidal ideation occurs in approximately 8–27% of PwHD, yet its causes remain unclear​(1–3)​. The…
  • 2026 International Congress

    Integrated and Multidisciplinary Care for Older Adults with Parkinson’s Disease: A value-driven approach

    P. Venugopalan Menon, M. Tan, W. Hong, E. Gondo Santoso, S. Kumari, A. Soh, S. Kumar Seetharaman (Singapore, Singapore)

    Objective: To evaluate value driven outcomes of an integrated multidisciplinary Parkinson’s clinic for older adults in Singapore Background: Parkinson’s Disease (PD) is a complex neurodegenerative…
  • 2026 International Congress

    Comparative efficacy and safety of Safinamide versus Opicapone in Japanese patients with Parkinson’s Disease and wearing-off: A matching-adjusted indirect comparison

    N. Nishikawa, R. Ando, T. Ishida, T. Hatano, N. Hattori, M. Nomoto (Tokyo, Japan)

    Objective: To compare efficacy and safety outcomes with safinamide and opicapone as adjuncts to levodopa in Parkinson’s disease (PD) patients with wearing-off using an anchored…
  • 2026 International Congress

    Real-World Mobile Voice Classification for Parkinson’s Disease Using Convolutional Neural Networks and Mel-Spectrogram Features

    N. Leabthong, J. Sringean, T. Laosombut, N. Jeh-Voh1, Z. Win, P. Rattanajun, S. Phumphid, C. Anan, J. Meesri, S. Wekhinhiran, O. Phokaewvarangkul, P. Panyakaew, S. Maytharakcheep, P. Jagota, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate the performance of deep learning approach based on Mel-spectrogram features in classifying PD using two real-world speech tasks - sustained phonation and…
  • 2026 International Congress

    Association of Glymphatic Flow at Diffusion Tensor Image with Motor Symptoms and Striatal Dopamine Degeneration in Parkinson’s Disease

    SJ. Chung, CJ. Park, PH. Lee, YH. Sohn, YJ. Kim (Seoul, Republic of Korea)

    Objective: This study aimed to investigate the association between the diffusion tensor image (DTI) analysis along the perivascular space (ALPS) index, dopamine transporter (DAT) availability…
  • 2026 International Congress

    Early Clinical Characteristics of Pathologically Confirmed Progressive Supranuclear Palsy and Corticobasal Degeneration

    SKS. Ting, S. Asahara Thio, K. Cao, S. Hameed, WS. Li, J. Mukesh Shah, S. Lin, JW. Sim, HJ. Chiew, KP. Ng, ASL. Ng (Singapore, Singapore)

    Objective: This study aimed to characterize the early clinical features of PSP and CBD to inform clinicians on diagnostic assessment and management strategies. Background: Although…
  • 2026 International Congress

    Qihuang Needle Therapy for Motor Symptoms in Parkinson’s Disease: A Randomized Controlled Trial

    WQ. Peng, RH. Zhao, ZT. Huang, NB. Wang, ZH. Chen (Guangzhou, China)

    Objective: To evaluate the efficacy of Qihuang needle therapy for improving motor and non-motor symptoms in patients with Parkinson’s disease (PD). Background: Motor symptoms in…
  • 2026 International Congress

    Risk factors for dysautonomic fluctuations in Mexican PwP

    MF. Medina-Pérez, MF. Velasco-Delgado, A. Cervantes-Arriaga, R. Solís-Vivanco, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To identify risk factors for non-motor dysautonomic fluctuations in people living with Parkinson’s disease (PwP). Background: Advanced Parkinson’s disease (PD) is characterized by motor…
  • 2026 International Congress

    Digital Health, Telemedicine, and Artificial Intelligence in Parkinson’s Disease Management During COVID-19: A Narrative Review

    H. Harifi (Kenitra, Morocco)

    Objective: The objective of this narrative review was to evaluate the effectiveness of telemedicine and AI-based technologies used for the remote monitoring and management of…
  • « Previous Page
  • 1
  • …
  • 78
  • 79
  • 80
  • 81
  • 82
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley